 Pieris Pharmaceuticals, Inc. NASDAQ:PIRS Q2 2022 Results Conference Call August 4, 2022 8:00 AM ET Company Participants Tom Bures - Chief Financial Officer Steve Yoder - President and Chief Executive Officer Hitto Kaufmann - Chief Scientific Officer Shane Olwill - Chief Development Officer Conference Call Participants Roger Song - Jefferies Jonathan Miller - Evercore ISI Matt Phipps - William Blair Operator Good morning, ladies and gentlemen, and welcome to the Pieris Pharmaceuticals Second Quarter Earnings Call. I will now turn the program over to Tom Bures, Chief Financial Officer. 